Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
Download
Download
DownloadPreview
Nanocarrier-mediated_cancer_therapy_with_cisplati.pdf
- Published Version
(30MB)
| Preview
Available under license: Creative Commons Attribution
Export
Ranasinghe, Ranmali 
ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122, Abdullah Alshawsh, Mohammed and Zulli, Anthony ORCID: 0000-0002-2660-078X
(2024)
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm.
Heliyon, 10 (7).
ISSN 2405-8440
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/48623 |
| DOI | 10.1016/j.heliyon.2024.e28171 |
| Official URL | https://www.sciencedirect.com/science/article/pii/... |
| Subjects | Current > FOR (2020) Classification > 3211 Oncology and carcinogenesis Current > Division/Research > Institute for Health and Sport |
| Keywords | cisplatin; nanocarriers; nanotechnology; nanomedicine; meta-analysis; cancer cell viability; tumour volumeI; C50; biodistribution of platinum in vital organs |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)